Znanstveni rad - Izvorni znanstveni rad
Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development

Kosmac, Kate; Bantug, Glenn R.; Pernjak-Pugel, Ester; Cekinović, Đurđica; Jonjić, Stipan; Britt, William J. (2013)
Citirajte ovaj rad...

Kosmac, K., Bantug, G. R., Pernjak Pugel, E., Cekinović, ., Jonjić, S. i Britt, W. J. (2013). Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens, 9. (3). doi: 10.1371/journal.ppat.1003200

Kosmac, Kate, et al. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens, vol. 9, br. 3, 2013. https://doi.org/10.1371/journal.ppat.1003200

Kosmac, Kate, Glenn R. Bantug, Ester Pernjak Pugel, Đurđica Cekinović, Stipan Jonjić i William J. Britt. "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development." PLoS Pathogens 9, br. 3 (2013). https://doi.org/10.1371/journal.ppat.1003200

Kosmac, K., et al. (2013) 'Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development', PLoS Pathogens, 9(3). doi: 10.1371/journal.ppat.1003200

Kosmac K, Bantug GR, Pernjak Pugel E, Cekinović , Jonjić S, Britt WJ. Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development. PLoS Pathogens [Internet]. 07.03.2013. [pristupljeno 20.08.2019.];9(3). doi: 10.1371/journal.ppat.1003200

K. Kosmac, G. R. Bantug, E. Pernjak Pugel, . Cekinović, S. Jonjić i W. J. Britt, "Glucocortiocoid Treatment of MCMV Infected Newborn Mice Attenuates CNS Inflammation and Limits Deficits in Cerebellar Development", PLoS Pathogens, vol. 9, br. 3, Ožujak 2013. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:792777. [Citirano: 20.08.2019.]